{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:12:21Z","timestamp":1787631141807,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.clineuro.2023.107899","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T09:24:02Z","timestamp":1689499442000},"page":"107899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The value of serum Lp-PLA2 combined with MPO in the diagnosis of cerebral infarction caused by large artery atherosclerosis"],"prefix":"10.1016","volume":"232","author":[{"given":"Min","family":"Hua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun-Lin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2023.107899_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fneur.2011.00006","article-title":"Chinese ischemic stroke subclassification","volume":"2","author":"Gao","year":"2011","journal-title":"Front Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2023.107899_bib2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/01.STR.31.5.1062","article-title":"Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence","volume":"31","author":"Petty","year":"2000","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.clineuro.2023.107899_bib3","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3390\/antiox11050874","article-title":"Unexpected role of MPO-oxidized LDLs in atherosclerosis: in between inflammation and its resolution","volume":"11","author":"Tangeten","year":"2022","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.clineuro.2023.107899_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.118.034653","article-title":"Acute Ischemic stroke biology demands fast treatment","volume":"138","author":"Al Sultan","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.clineuro.2023.107899_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1570161118666200318104434","article-title":"Inflammatory markers in cardiovascular disease; lessons learned and future perspectives","volume":"19","author":"Patoulias","year":"2021","journal-title":"Curr. Vasc. Pharm."},{"issue":"2","key":"10.1016\/j.clineuro.2023.107899_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1006\/bbrc.1999.1066","article-title":"Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma","volume":"261","author":"Asano","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clineuro.2023.107899_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1567-5688(02)00045-4","article-title":"Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase","volume":"3","author":"Tselepis","year":"2002","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.clineuro.2023.107899_bib8","first-page":"327","article-title":"The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma","volume":"2009","author":"Tellis","year":"1791","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.clineuro.2023.107899_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083393","article-title":"Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the Northern Manhattan Study","volume":"9","author":"Katan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clineuro.2023.107899_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2017.09.013","article-title":"Prognostic value of lipoprotein-associated phospholipase A2 mass for all-cause mortality and vascular events within one year after acute ischemic stroke","volume":"266","author":"Han","year":"2017","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.clineuro.2023.107899_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/WNR.0000000000000765","article-title":"The elevated lipoprotein-associated phospholipase A2 activity is associated with the occurrence and recurrence of acute cerebral infarction","volume":"28","author":"Wei","year":"2017","journal-title":"Neuroreport"},{"issue":"19","key":"10.1016\/j.clineuro.2023.107899_bib12","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/archinte.166.19.2073","article-title":"High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke","volume":"166","author":"Elkind","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.clineuro.2023.107899_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000172633","article-title":"Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke","volume":"27","author":"Elkind","year":"2009","journal-title":"Cereb. Dis."},{"issue":"47","key":"10.1016\/j.clineuro.2023.107899_bib14","doi-asserted-by":"crossref","first-page":"18584","DOI":"10.1073\/pnas.0803945105","article-title":"Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase","volume":"105","author":"Breckwoldt","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.clineuro.2023.107899_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/13510002.2016.1256119","article-title":"The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture","volume":"22","author":"Teng","year":"2017","journal-title":"Redox Rep."},{"issue":"8","key":"10.1016\/j.clineuro.2023.107899_bib16","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1373\/clinchem.2009.126029","article-title":"Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?","volume":"55","author":"Schindhelm","year":"2009","journal-title":"Clin. Chem."},{"issue":"17","key":"10.1016\/j.clineuro.2023.107899_bib17","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","article-title":"Association between myeloperoxidase levels and risk of coronary artery disease","volume":"286","author":"Zhang","year":"2001","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.clineuro.2023.107899_bib18","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jacc.2009.11.050","article-title":"Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography","volume":"55","author":"Heslop","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.clineuro.2023.107899_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.clineuro.2023.107899_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3349\/ymj.2017.58.1.114","article-title":"Increased risk of cardiovascular events in stroke patients who had not undergone evaluation for coronary artery disease","volume":"58","author":"Kim","year":"2017","journal-title":"Yonsei Med. J."},{"issue":"9","key":"10.1016\/j.clineuro.2023.107899_bib21","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/jcbfm.2014.102","article-title":"Ablation of MMP9 gene ameliorates paracellular permeability and fibrinogen-amyloid beta complex formation during hyperhomocysteinemia","volume":"34","author":"Muradashvili","year":"2014","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.clineuro.2023.107899_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21950","article-title":"Body mass index and risk of stroke among Chinese men and women","volume":"67","author":"Bazzano","year":"2010","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2023.107899_bib23","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.0000280571.28102.d4","article-title":"New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease","volume":"27","author":"Tsimikas","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.clineuro.2023.107899_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1155\/2013\/432136","article-title":"Lipoprotein-associated phospholipase A2 (Lp-PLA(2)): a novel and promising biomarker for cardiovascular risks assessment","volume":"34","author":"Cai","year":"2013","journal-title":"Dis. Markers"},{"key":"10.1016\/j.clineuro.2023.107899_bib25","article-title":"Elevated lipoprotein-associated phospholipase A2 is associated with intracranial atherosclerosis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2023.107899_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23084","article-title":"Evaluation of lipoprotein-associated phospholipase A2, serum amyloid A, and fibrinogen as diagnostic biomarkers for patients with acute cerebral infarction","volume":"34","author":"Tao","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"issue":"4","key":"10.1016\/j.clineuro.2023.107899_bib27","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.024","article-title":"Lipoprotein-associated phospholipase A2 during the hyperacute stage of ischemic and hemorrhagic strokes","volume":"23","author":"Rosso","year":"2014","journal-title":"J. Stroke Cereb. Dis."},{"issue":"2","key":"10.1016\/j.clineuro.2023.107899_bib28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.atherosclerosis.2011.11.016","article-title":"Temporal profile and prognostic value of Lp-PLA2 mass and activity in the acute stroke setting","volume":"220","author":"Delgado","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.clineuro.2023.107899_bib29","first-page":"33","article-title":"Myeloperoxidase as an active disease biomarker: recent biochemical and pathological perspectives","volume":"6","author":"Khan","year":"2018","journal-title":"Med. Sci."},{"issue":"1","key":"10.1016\/j.clineuro.2023.107899_bib30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/cvr\/cvac081","article-title":"Arterial myeloperoxidase in the detection and treatment of vulnerable atherosclerotic plaque: a new dawn for an old light","volume":"119","author":"Nadel","year":"2023","journal-title":"Cardiovasc. Res."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846723003153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846723003153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:45:38Z","timestamp":1759589138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846723003153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":30,"alternative-id":["S0303846723003153"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2023.107899","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of serum Lp-PLA2 combined with MPO in the diagnosis of cerebral infarction caused by large artery atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2023.107899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107899"}}